Zimmer Biomet Holdings Inc
ZBHHealthcare·Medical Devices·USA·Large·NYSE·Nov 11 • 3:59 PM ET
107.47+0.15 (0.14%)
2026-11-12 03:02 CET
Market cap
20,339.13 USD m
Revenue, TTM
8,570.40 USD m
Net income, TTM
767.30 USD m
Free cash flow, TTM
1,294.80 USD m
EPS diluted, TTM
3.95
P/E
27.22
Price
ZBH against its 20, 50 and 200-day averages2050200beatmiss
4.5% under the 52-week high of 112.55 on 4 Nov 2026. 52-week low 79.12 on 11 May 2026. Last 15 sessions, 19.2% high to low
Volume 0.62× normal · the line is the 50-bar volume average
Profile
ZBH52-week range, 85% of the way up
79.12112.54
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
| Index | S&P 500, RUI |
|---|---|
| Employees | 17000 |
| IPO | Jul 25, 2001 |
| Beta | 0.46 |
| ATR, 14d | 3.26 |
| Rel volume | 0.62 |
| Short float | 4.15% |
| Insider own | 0.18% |
| Inst own | 106.81% |
Snapshot
6 groupsValuation
| Index | S&P 500, RUI |
|---|---|
| Market Cap | 20.34B |
| Enterprise Value | 27.45B |
| Income | 767.30M |
| Sales | 8.57B |
| Book/sh | 66.89 |
| Cash/sh | 2.11 |
| Dividend Est. | 1.04 (0.96%) |
| Dividend TTM | 0.96 (0.89%) |
| Dividend Ex-Date | Sep 30, 2026 |
| Dividend Gr. 3/5Y | 0.00% 0.00% |
| Payout | 27.05% |
| Employees | 17000 |
| IPO | Jul 25, 2001 |
Ratios
| P/E | 27.22 |
|---|---|
| Forward P/E | 11.97 |
| PEG | 2.14 |
| P/S | 2.37 |
| P/B | 1.61 |
| P/C | 50.86 |
| P/FCF | 15.71 |
| EV/EBITDA | 10.92 |
| EV/Sales | 3.20 |
| Quick Ratio | 0.79 |
| Current Ratio | 1.46 |
| Debt/Eq | 0.59 |
| LT Debt/Eq | 0.49 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 3.95 |
|---|---|
| EPS next Y | 8.98 |
| EPS next Q | 2.49 |
| EPS this Y | 4.32% |
| EPS next Y | 4.99% |
| EPS next 5Y | 5.58% |
| EPS past 3/5Y | 47.75% - |
| Sales past 3/5Y | 5.85% 3.22% |
| EPS Y/Y TTM | -2.22% |
| Sales Y/Y TTM | 6.98% |
| EPS Q/Q | -13.82% |
| Sales Q/Q | 3.07% |
| Earnings | Nov 04 BMO |
| EPS/Sales Surpr. | 0.99% 1.13% |
Ownership
| Insider Own | 0.18% |
|---|---|
| Insider Trans | -3.86% |
| Inst Own | 106.81% |
| Inst Trans | 1.33% |
| ROA | 3.26% |
| ROE | 6.03% |
| ROIC | 4.05% |
| Gross Margin | 61.43% |
| Oper. Margin | 16.43% |
| Profit Margin | 8.95% |
| SMA20 | 7.76% |
| SMA50 | 12.44% |
| SMA200 | 16.38% |
| Trades | - |
Technical
| Shs Outstand | 190.10M |
|---|---|
| Shs Float | 188.92M |
| Short Float | 4.15% |
| Short Ratio | 3.75 |
| Short Interest | 7.85M |
| 52W High | 112.54 -4.51% |
| 52W Low | 79.12 35.83% |
| Volatility | 3.11% 2.91% |
| ATR (14) | 3.26 |
| RSI (14) | 65.24 |
| Beta | 0.46 |
| Rel Volume | 0.62 |
| Avg Volume | 2.09M |
| Volume | 1,296,362 |
Performance
| Perf Week | -2.43% |
|---|---|
| Perf Month | 16.71% |
| Perf Quarter | 7.93% |
| Perf Half Y | 29.92% |
| Perf YTD | 19.52% |
| Perf Year | 21.44% |
| Perf 3Y | 1.94% |
| Perf 5Y | -16.51% |
| Perf 10Y | 13.01% |
| Recom | 2.57 |
| Target Price | 116.05 |
| Prev Close | 107.32 |
| Price | 107.47 |
| Change % | 0.14% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 07, 2026 | Initiated | BBarclays | Equal Weight | $100 | -7.0% |
| Jul 28, 2026 | Initiated | UUBS | Buy | $115 | +7.0% |
| Jul 09, 2026 | Initiated | BBMO Capital Markets | Market Perform | $95 | -11.6% |
| Mar 23, 2026 | Downgrade | BBTIG Research | Buy → Neutral | ||
| Feb 20, 2026 | Initiated | WWilliam Blair | Mkt Perform | ||
| Jan 09, 2026 | Downgrade | GGoldman | Neutral → Sell | $93 | -13.5% |
| Jan 06, 2026 | Downgrade | RRaymond James | Outperform → Mkt Perform | ||
| Jan 05, 2026 | Upgrade | EEvercore ISI | In-line → Outperform | $210 | +95.4% |
| Dec 16, 2025 | Downgrade | RRobert W. Baird | Outperform → Neutral | $100 | -7.0% |
| Nov 06, 2025 | Downgrade | JJP Morgan | Overweight → Neutral | $100 | -7.0% |
Peers
Mkt capInsider trading
latest 14 of 39| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Campbell Gary Craig | President, Americas | Oct 01 '26 | Option Exercise | 0.00 | 3,586 | 0 | 2,654 | Oct 05 04:12 PM |
| Thornal Kevin R | Grp Pres-Global Business | Sep 11 '26 | Sale | 92.95 | 5,691 | 528,978 | 0 | Sep 15 04:24 PM |
| Thornal Kevin R | Officer | Sep 11 '26 | Proposed Sale | 92.95 | 5,691 | 528,978 | Sep 11 10:11 AM | |
| Phipps Chad F | See remarks below. | Sep 04 '26 | Sale | 98.35 | 3,000 | 295,050 | 65,231 | Sep 09 04:12 PM |
| Phipps Chad F | Officer | Sep 04 '26 | Proposed Sale | 98.35 | 3,000 | 295,050 | Sep 04 04:01 PM | |
| Thornal Kevin R | Grp Pres-Global Business | Aug 01 '26 | Option Exercise | 0.00 | 9,957 | 0 | 9,957 | Aug 04 04:18 PM |
| Upadhyay Suketu | Former Officer | Jul 16 '26 | Proposed Sale | 92.86 | 7,668 | 712,050 | Jul 16 03:13 PM | |
| Upadhyay Suketu | Former Officer | Jun 24 '26 | Proposed Sale | 90.07 | 4,560 | 410,696 | Jun 24 11:46 AM | |
| Yi Sang | Group President, Asia Pacific | May 29 '26 | Sale | 82.64 | 5,000 | 413,216 | 27,251 | Jun 02 04:35 PM |
| Yi Sang | Officer | May 29 '26 | Proposed Sale | 82.64 | 5,000 | 413,216 | May 29 02:21 PM | |
| Upadhyay Suketu | Former Officer | May 19 '26 | Proposed Sale | 86.38 | 5,373 | 464,120 | May 19 03:19 PM | |
| Upadhyay Suketu | Former Officer | May 12 '26 | Proposed Sale | 83.48 | 31,253 | 2,608,859 | May 12 02:47 PM | |
| Noor Jehanzeb | See remarks below. | Apr 01 '26 | Option Exercise | 0.00 | 6,626 | 0 | 6,828 | Apr 03 04:03 PM |
| Winkler Lori | SVP and CHRO | Mar 12 '26 | Sale | 94.66 | 2,650 | 250,849 | 10,224 | Mar 16 04:12 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| VOO | Vanguard S&P 500 ETF | AUM: 1054.75B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 79.59B |
| MOAT | VanEck Morningstar Wide Moat ETF | AUM: 12.18B |
| IVV | iShares Core S&P 500 ETF | AUM: 871.38B |
| SPY | SPDR S&P 500 ETF Trust | AUM: 793.23B |
| VBR | Vanguard Morningstar Small-Cap Value ETF | AUM: 37.76B |
| RSP | Invesco S&P 500 Equal Weight ETF | AUM: 104.94B |
| XLV | State Street Health Care Select Sector SPDR ETF | AUM: 50.35B |
| IHI | iShares U.S. Medical Devices ETF | AUM: 4.07B |
News
latest 14 of 200- Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London (PR Newswire)
- Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery (PR Newswire)
- Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +13.49%
- Zimmer Biomet Raises Guidance Again On Hips And S.E.T., But Flat EPS And A Knee Slide Leave It Short Of The Whisper (Earnings Whispers)
- Zimmer raises sales forecast despite slower knee business (MedTech Dive)
- Zimmer Biomet stock rises 9% after reporting positive Q3 (Medical Device Network)
- Zimmer: Q3 Earnings Snapshot (Associated Press)
- Zimmer Biomet Announces Third Quarter 2026 Financial Results (PR Newswire)
- Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026 (PR Newswire)
- Zimmer Biomet's Sales-Force Overhaul Faces Its First Post-Raise Test As Margins Linger (Earnings Whispers)
- Expect more tuck-in M&A, portfolio pruning in medtech, execs say (MedTech Dive)
- Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market (The Wall Street Journal)
- ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT (PR Newswire)
- Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-04 | 1.900 | 1.881 | 1.000 | 2,063 | 2,040 | 25 |
| 2026Q2 | 2026-08-05 | 2.070 | 2.010 | 1.029 | 2,177 | 2,135 | 25 |
| 2026Q1 | 2026-04-28 | 2.090 | 1.865 | 1.216 | 2,087 | 2,071 | 26 |
| 2025Q4 | 2026-02-10 | 2.420 | 2.398 | 0.703 | 2,244 | 2,224 | 26 |
| 2025Q3 | 2025-11-05 | 1.900 | 1.866 | 1.162 | 2,001 | 2,012 | 25 |
| 2025Q2 | 2025-08-07 | 2.070 | 1.979 | 0.771 | 2,077 | 2,057 | 25 |
| 2025Q1 | 2025-05-05 | 1.810 | 1.771 | 0.911 | 1,909 | 1,895 | 27 |
| 2024Q4 | 2025-02-06 | 2.310 | 2.295 | 1.198 | 2,023 | 2,014 | 28 |
| 2024Q3 | 2024-10-30 | 1.740 | 1.744 | 1.227 | 1,824 | 1,798 | 28 |
| 2024Q2 | 2024-08-07 | 2.010 | 1.991 | 1.176 | 1,942 | 1,940 | 27 |
| 2024Q1 | 2024-05-02 | 1.940 | 1.870 | 0.836 | 1,889 | 1,867 | 26 |
| 2023Q4 | 2024-02-08 | 2.200 | 2.154 | 2.010 | 1,940 | 1,928 | 26 |
| 2023Q3 | 2023-11-07 | 1.650 | 1.598 | 0.775 | 1,754 | 1,749 | 26 |
| 2023Q2 | 2023-08-01 | 1.820 | 1.818 | 0.999 | 1,870 | 1,826 | 25 |
| 2023Q1 | 2023-05-02 | 1.890 | 1.639 | 1.105 | 1,831 | 1,704 | 25 |
| 2022Q4 | 2023-02-03 | 1.880 | 1.828 | -0.622 | 1,825 | 1,761 | 25 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 7.635 | 7.601 | 5.475 | 7,982 | 7,963 |
| 2020FY | 5.501 | 5.463 | -0.671 | 7,025 | 7,023 |
| 2021FY | 7.150 | 7.172 | 1.909 | 7,836 | 7,862 |
| 2022FY | 6.890 | 6.839 | 1.100 | 6,940 | 6,874 |
| 2023FY | 7.550 | 7.512 | 4.883 | 7,394 | 7,382 |
| 2024FY | 8.000 | 7.983 | 4.433 | 7,679 | 7,670 |
| 2025FY | 8.200 | 8.176 | 3.550 | 8,232 | 8,211 |
| 2026FY | - | 8.554 | - | - | 8,615 |
| 2027FY | - | 8.981 | - | - | 8,901 |
| 2028FY | - | 9.649 | - | - | 9,248 |
| 2029FY | - | 10.268 | - | - | 9,617 |
| 2030FY | - | 10.745 | - | - | 9,977 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-06 | 23 | 0 | 1 | 2,288 | 2,270 | 2,301 |
| 2026Q4 | S | 2026-11-04 | 23 | 0 | 1 | 2,288 | 2,270 | 2,301 |
| 2026Q4 | S | 2026-10-15 | 23 | 0 | 0 | 2,293 | 2,283 | 2,307 |
| 2026Q4 | S | 2026-10-09 | 24 | 0 | 0 | 2,293 | 2,283 | 2,307 |
| 2026Q4 | S | 2026-09-25 | 24 | 0 | 0 | 2,293 | 2,283 | 2,312 |
| 2026Q4 | S | 2026-08-19 | 24 | 0 | 0 | 2,293 | 2,283 | 2,312 |
| 2026Q4 | S | 2026-08-12 | 24 | 0 | 0 | 2,293 | 2,283 | 2,312 |
| 2026Q4 | S | 2026-08-06 | 24 | 0 | 0 | 2,293 | 2,283 | 2,312 |
| 2026Q4 | S | 2026-08-05 | 24 | 0 | 0 | 2,293 | 2,283 | 2,312 |
| 2026Q4 | S | 2026-07-27 | 24 | 0 | 0 | 2,287 | 2,268 | 2,312 |
| 2026Q4 | S | 2026-07-15 | 23 | 0 | 0 | 2,287 | 2,268 | 2,312 |
| 2026Q4 | S | 2026-07-14 | 23 | 0 | 0 | 2,287 | 2,268 | 2,312 |
| 2026Q4 | S | 2026-07-13 | 24 | 0 | 0 | 2,285 | 2,250 | 2,312 |
| 2026Q4 | S | 2026-07-12 | 24 | 0 | 0 | 2,286 | 2,265 | 2,312 |
Estimate history
| EPS, annual | 8.904 | -1.863 | 5.475 | -0.671 | 1.909 | 1.1 | 4.883 | 4.433 | 3.549 | 3.9488 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 1.227 | 1.198 | 0.911 | 0.771 | 1.162 | 0.703 | 1.216 | 1.029 | 1.001 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 7803.3 | 7932.9 | 7982.2 | 7024.5 | 6827.3 | 6939.9 | 7394.2 | 7678.6 | 8231.5 | 8570.4 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 1824.2 | 2023.2 | 1909.1 | 2077.3 | 2001.4 | 2243.8 | 2086.7 | 2177 | 2062.9 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 202.6 | 204 | 206 | 207.6 | 209 | 209 | 205.6 | 199.1 | 195.5 | 190.1 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 199.6 | 199.1 | 197.9 | 197.9 | 198.2 | 195.5 | 193.4 | 190.6 | 190.1 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,570.40 | 8,231.50 | 7,678.60 | 7,394.20 | 6,939.90 | 6,827.30 | 7,024.50 | 7,982.20 | 7,932.90 |
| Cost of Goods Sold Incl. D&A | 3,305.80 | 3,215.70 | 2,856.90 | 2,731.20 | 2,601.10 | 2,489.10 | 2,771.30 | 2,875.30 | 2,841.60 |
| Gross Profit | 5,264.60 | 5,015.80 | 4,821.70 | 4,663.00 | 4,338.80 | 4,338.20 | 4,253.20 | 5,106.90 | 5,091.30 |
| Selling, General and Administrative Excl. Other | 3,856.50 | 3,693.00 | 3,336.70 | 3,276.00 | 3,101.80 | 3,078.20 | 3,390.00 | 3,816.60 | 3,771.00 |
| Research and Development | 432.90 | 458.50 | 437.40 | 458.70 | 406.00 | 435.80 | 372.00 | 449.30 | 391.70 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 33.80 | 52.80 | 50.90 | 82.40 | 146.90 |
| Operating Income | 1,408.10 | 1,322.80 | 1,485.00 | 1,387.00 | 1,203.20 | 1,207.20 | 812.30 | 1,207.90 | 1,173.40 |
| Interest Expense | 287.80 | 284.10 | 207.10 | 195.30 | 164.10 | 207.80 | 211.40 | 229.10 | 292.00 |
| Unusual Expense | 290.00 | 271.70 | 326.40 | 201.70 | 703.30 | 513.00 | 934.90 | 119.80 | 1,088.70 |
| Net Income Before Taxes | 884.50 | 830.80 | 1,036.60 | 1,067.30 | 403.50 | 499.00 | -274.40 | 905.80 | -271.10 |
| Income Taxes | 115.80 | 125.70 | 131.40 | 42.20 | 112.30 | 53.50 | -137.00 | -225.70 | 108.20 |
| Consolidated Net Income | 768.70 | 705.00 | 905.20 | 1,025.10 | 291.20 | 445.50 | -137.40 | 1,131.50 | -379.30 |
| Net Income From Continuing Operations | 767.40 | 705.10 | 903.70 | 1,024.00 | 290.20 | 445.00 | -138.90 | 1,131.60 | -379.20 |
| Net Income | 767.30 | 705.10 | 903.80 | 1,024.00 | 231.40 | 401.60 | -138.90 | 1,131.60 | -379.20 |
| EPS (Recurring) | 5.07 | 4.51 | 5.55 | 5.56 | 3.44 | 3.62 | 2.49 | 5.88 | 1.88 |
| EPS (Basic, Before Extraordinaries) | 3.96 | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 | -0.67 | 5.52 | -1.86 |
| EPS (Diluted) | 3.95 | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 | -0.67 | 5.47 | -1.86 |
| EBITDA | 2,514.90 | 2,416.60 | 2,481.30 | 2,338.70 | 2,129.60 | 2,144.80 | 1,845.00 | 2,214.00 | 2,211.90 |
| Non-Operating Income (Expense) | 54.20 | 63.80 | 85.10 | 77.30 | 67.70 | 12.60 | 59.60 | 46.80 | -63.80 |
| Other After Tax Adjustments | 0.00 | -0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 82.50 | 92.30 | 83.10 | 88.10 | 58.80 | 62.80 | 62.50 | 50.90 |
| Price To Earnings Ratio | 27.22 | 27.22 | 20.12 | 53.94 | 96.68 | 64.69 | - | 26.55 | - |
| Price To Sales Ratio | 1.98 | 2.17 | 2.80 | 3.45 | 3.86 | 3.92 | 4.54 | 3.88 | 2.66 |
| Gross Margin | 61.43 | 60.93 | 62.79 | 63.06 | 62.52 | 63.54 | 60.55 | 63.98 | 64.18 |
| Operating Margin | 16.43 | 16.07 | 19.34 | 18.76 | 17.34 | 17.68 | 11.56 | 15.13 | 14.79 |
| Net Margin | 8.95 | 8.57 | 11.77 | 13.85 | 3.33 | 5.88 | -1.98 | 14.18 | -4.78 |
| Shares Outstanding | 190.10 | 195.50 | 199.10 | 205.60 | 209.00 | 209.00 | 207.60 | 206.00 | 204.00 |
| Market Capitalization | 20,339.13 | 20,339.13 | 21,028.19 | 25,432.99 | 26,756.13 | 25,746.76 | 30,985.23 | 29,866.98 | 20,524.31 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,062.90 | 2,177.00 | 2,086.70 | 2,243.80 | 2,001.40 | 2,077.30 | 1,909.10 | 2,023.20 |
| Cost of Goods Sold Incl. D&A | 770.10 | 807.50 | 746.10 | 982.10 | 746.50 | 767.00 | 719.90 | 762.00 |
| Gross Profit | 1,292.80 | 1,369.50 | 1,340.60 | 1,261.70 | 1,254.90 | 1,310.30 | 1,189.20 | 1,261.20 |
| Selling, General and Administrative Excl. Other | 943.10 | 986.30 | 948.30 | 978.80 | 924.20 | 922.80 | 867.30 | 827.90 |
| Research and Development | 105.90 | 104.80 | 103.40 | 118.80 | 115.90 | 113.30 | 110.60 | 108.40 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 349.70 | 383.20 | 392.30 | 282.90 | 330.70 | 387.50 | 321.90 | 433.30 |
| Interest Expense | 74.30 | 73.30 | 69.20 | 71.00 | 73.80 | 75.80 | 63.30 | 59.20 |
| Unusual Expense | 64.30 | 63.70 | 28.50 | 133.50 | -17.80 | 115.30 | 55.90 | 67.50 |
| Net Income Before Taxes | 230.10 | 255.10 | 301.30 | 98.00 | 279.20 | 224.60 | 229.00 | 289.00 |
| Income Taxes | 37.20 | 55.50 | 63.00 | -39.90 | 48.00 | 71.20 | 46.50 | 49.00 |
| Consolidated Net Income | 192.90 | 199.60 | 238.30 | 137.90 | 231.20 | 153.40 | 182.60 | 240.00 |
| Net Income From Continuing Operations | 191.60 | 198.30 | 238.10 | 139.40 | 230.90 | 152.80 | 182.00 | 239.40 |
| Net Income | 191.60 | 198.30 | 238.10 | 139.30 | 230.90 | 152.80 | 182.00 | 239.40 |
| EPS (Recurring) | 1.24 | 1.26 | 1.32 | 1.17 | 1.10 | 1.18 | 1.11 | 1.43 |
| EPS (Basic, Before Extraordinaries) | 1.01 | 1.03 | 1.22 | 0.71 | 1.17 | 0.77 | 0.92 | 1.20 |
| EPS (Diluted) | 1.00 | 1.03 | 1.22 | 0.70 | 1.16 | 0.77 | 0.91 | 1.20 |
| EBITDA | 631.70 | 654.00 | 662.30 | 566.90 | 614.30 | 659.30 | 576.30 | 696.90 |
| Non-Operating Income (Expense) | 19.00 | 8.90 | 6.80 | 19.50 | 4.50 | 28.20 | 26.30 | -17.60 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 28.84 | - | - | - | - | 17.22 | 16.59 | 16.27 |
| Price To Earnings Ratio | 27.22 | 22.35 | 25.49 | 22.25 | 23.99 | 20.21 | 25.51 | 20.12 |
| Price To Sales Ratio | 1.98 | 1.95 | 2.11 | 2.16 | 2.44 | 2.31 | 2.94 | 2.75 |
| Gross Margin | 62.67 | 62.91 | 64.24 | 56.23 | 62.70 | 63.08 | 62.29 | 62.34 |
| Operating Margin | 16.95 | 17.60 | 18.80 | 12.61 | 16.52 | 18.65 | 16.86 | 21.42 |
| Net Margin | 9.29 | 9.11 | 11.41 | 6.21 | 11.54 | 7.36 | 9.53 | 11.83 |
| Shares Outstanding | 190.10 | 190.60 | 193.40 | 195.50 | 198.20 | 197.90 | 197.90 | 199.10 |
| Market Capitalization | 20,339.13 | 16,655.14 | 17,690.85 | 17,820.53 | 19,512.46 | 18,045.72 | 22,529.95 | 21,028.19 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 591.90 | 525.50 | 415.80 | 375.70 | 378.10 | 802.10 | 617.90 | 542.80 | 524.40 |
| Short Term Receivables | 1,704.40 | 1,480.70 | 1,442.40 | 1,381.50 | 1,259.60 | 1,452.70 | 1,363.90 | 1,275.80 | 1,544.10 |
| Inventories | 2,286.40 | 2,235.30 | 2,385.20 | 2,147.20 | 2,148.00 | 2,450.70 | 2,385.00 | 2,256.50 | 2,068.30 |
| Other Current Assets | 537.20 | 430.00 | 366.10 | 522.90 | 1,099.30 | 377.80 | 357.10 | 352.30 | 428.00 |
| Total Current Assets | 5,119.90 | 4,671.50 | 4,609.50 | 4,427.30 | 4,885.00 | 5,083.30 | 4,723.90 | 4,427.40 | 4,564.80 |
| Net Property, Plant & Equipment | 2,411.30 | 2,262.30 | 2,264.20 | 2,068.90 | 2,056.00 | 2,322.20 | 2,344.10 | 2,015.40 | 2,038.60 |
| Total Investments and Advances | 39.40 | 73.20 | 31.60 | 16.60 | 27.60 | 3.70 | 70.30 | 38.80 | 9.30 |
| Intangible Assets | 14,664.40 | 13,549.50 | 13,674.90 | 13,644.00 | 14,453.00 | 16,317.30 | 16,857.30 | 17,279.00 | 19,021.80 |
| Other Assets | 856.70 | 808.80 | 916.70 | 909.20 | 2,034.80 | 691.20 | 643.10 | 366.20 | 379.50 |
| Total Assets | 23,091.70 | 21,365.30 | 21,496.90 | 21,066.00 | 23,456.40 | 24,417.70 | 24,638.70 | 24,126.80 | 26,014.00 |
| Short Term Debt Incl. Current Port. of LT Debt | 644.60 | 863.00 | 952.90 | 597.30 | 1,661.80 | 575.00 | 1,564.20 | 525.00 | 1,225.00 |
| Accounts Payable | 291.30 | 184.20 | 379.80 | 337.10 | 306.20 | 305.60 | 400.90 | 362.60 | 330.20 |
| Income Tax Payable | - | - | 61.20 | 38.50 | 62.00 | 59.50 | 126.70 | 142.40 | 165.20 |
| Other Current Liabilities | 1,647.80 | 1,403.70 | 1,463.50 | 1,385.30 | 1,437.90 | 1,616.80 | 1,349.70 | 1,391.30 | 1,349.30 |
| Total Current Liabilities | 2,583.70 | 2,450.90 | 2,857.40 | 2,358.20 | 3,467.90 | 2,556.90 | 3,441.50 | 2,421.30 | 3,069.70 |
| Long Term Debt | 7,107.50 | 5,531.80 | 5,042.30 | 5,319.50 | 5,638.60 | 7,844.30 | 6,936.90 | 8,413.70 | 8,917.50 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 124.40 | 0.00 | 72.10 | 0.00 |
| Deferred Tax Liabilities | 244.10 | 352.50 | 357.60 | 474.80 | 558.50 | 790.40 | 840.10 | 999.50 | 1,101.50 |
| Other Liabilities | 450.60 | 553.90 | 751.40 | 886.50 | 1,125.00 | 902.30 | 1,027.40 | 944.10 | 1,189.80 |
| Total Liabilities | 10,385.90 | 8,889.10 | 9,008.70 | 9,039.00 | 10,790.00 | 12,218.30 | 12,245.90 | 12,850.70 | 14,278.50 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 12,697.70 | 12,468.10 | 12,480.50 | 12,020.30 | 12,660.70 | 12,194.20 | 12,388.10 | 11,271.30 | 11,735.80 |
| Total Shareholders Equity | 12,697.70 | 12,468.10 | 12,480.50 | 12,020.30 | 12,660.70 | 12,194.20 | 12,388.10 | 11,271.30 | 11,735.80 |
| Accumulated Minority Interest | 8.10 | 8.10 | 7.70 | 6.70 | 5.70 | 5.20 | 4.70 | 4.80 | -0.30 |
| Total Equity | 12,705.80 | 12,476.20 | 12,488.20 | 12,027.00 | 12,666.40 | 12,199.40 | 12,392.80 | 11,276.10 | 11,735.50 |
| Total Liabilities & Stockholders Equity | 23,091.70 | 21,365.30 | 21,496.90 | 21,066.00 | 23,456.40 | 24,417.70 | 24,638.70 | 24,126.80 | 26,014.00 |
| Book Value Per Share | 64.95 | 62.62 | 60.70 | 57.51 | 60.58 | 58.74 | 60.14 | 55.25 | 57.93 |
| Tangible Book Value Per Share | -10.06 | -5.43 | -5.81 | -7.77 | -8.58 | -19.86 | -21.70 | -29.45 | -35.96 |
| Full-Time Employees | 17,000 | 17,000 | 18,000 | 18,000 | 19,500 | 20,000 | 19,900 | 19,000 | 18,200 |
| Price to Book Ratio | 1.61 | 1.70 | 2.03 | 2.18 | 2.03 | 2.54 | 2.41 | 1.82 | 2.27 |
| Return on Assets | 3.17 | 4.22 | 4.81 | 1.30 | 1.86 | -0.57 | 4.64 | -1.51 | 6.88 |
| Return on Equity | 5.60 | 7.24 | 8.36 | 2.35 | 3.58 | -1.13 | 9.57 | -3.30 | 16.95 |
| Return on Invested Capital | 3.56 | 5.02 | 5.84 | 1.33 | 2.19 | -0.69 | 5.86 | -1.93 | 8.78 |
| Quick Ratio | 1.10 | 0.99 | 0.78 | 0.97 | 0.79 | 1.03 | 0.68 | 0.90 | 0.81 |
| Current Ratio | 1.98 | 1.91 | 1.61 | 1.88 | 1.41 | 1.99 | 1.37 | 1.83 | 1.49 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 768.80 | 705.10 | 905.20 | 1,025.10 | 291.20 | 445.50 | -137.40 | 1,131.50 | -379.30 |
| Depreciation | 1,106.80 | 1,093.80 | 996.30 | 951.70 | 926.40 | 937.70 | 1,032.70 | 1,006.10 | 1,040.50 |
| Other Funds (Non Cash) | 97.00 | 90.20 | 101.00 | 97.30 | 442.90 | 352.30 | 724.70 | 154.40 | 1,045.20 |
| Funds from Operations | 1,885.40 | 1,801.90 | 1,954.80 | 1,977.80 | 1,596.10 | 1,633.40 | 1,632.00 | 1,753.30 | 1,719.80 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.80 | -104.80 | -455.40 | -396.20 | -311.40 | -134.20 | -427.50 | -167.50 | 27.60 |
| Income Taxes Payable | -67.10 | -166.60 | -158.60 | -73.80 | -152.90 | -123.90 | -291.10 | 111.40 | -150.80 |
| Cash from Operating Activities | 1,884.60 | 1,697.10 | 1,499.40 | 1,581.60 | 1,284.70 | 1,499.20 | 1,204.50 | 1,585.80 | 1,747.40 |
| Capital Expenditures | -726.00 | -577.40 | -597.10 | -689.20 | -511.60 | -445.20 | -431.80 | -740.30 | -470.50 |
| Net Assets From Acquisitions | -526.30 | -1,393.20 | -276.30 | -134.90 | -99.80 | 0.00 | -235.50 | -37.10 | -15.30 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Purchase or Sale of Investments | 44.40 | -0.40 | 22.10 | 33.40 | 89.40 | 1.90 | 53.50 | 48.10 | 69.20 |
| Purchase of Investments | 4.90 | -0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 39.50 | 0.00 | 22.10 | 33.40 | 89.40 | 1.90 | 53.50 | 48.10 | 69.20 |
| Other Uses | -7.20 | -4.70 | -36.90 | 0.00 | -7.20 | -60.30 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 11.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -1,215.10 | -1,975.70 | -888.10 | -778.90 | -529.20 | -503.60 | -613.80 | -729.30 | -416.60 |
| Cash Dividends Paid | -186.70 | -190.30 | -196.00 | -200.90 | -201.20 | -200.10 | -198.50 | -196.70 | -195.20 |
| Change in Capital Stock | -801.80 | -447.30 | -785.90 | -591.10 | -48.30 | 122.50 | 129.80 | 158.20 | 107.90 |
| Repurchase of Common Pref Stock | -829.30 | -487.00 | -868.00 | -692.20 | -126.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 27.50 | 39.70 | 82.10 | 101.10 | 78.10 | 122.50 | 129.80 | 158.20 | 107.90 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -481.30 | 1,006.40 | 523.30 | 48.80 | -1,062.30 | -1,068.20 | -275.20 | -716.10 | -1,154.40 |
| Change in Long Term Debt | -481.30 | 1,006.40 | 523.30 | 82.70 | -902.40 | -1,068.20 | -275.20 | -716.10 | -1,154.40 |
| Issuance of Long Term Debt | 118.70 | 2,469.40 | 1,423.30 | 494.00 | 593.40 | 1,586.60 | 1,474.80 | 749.20 | 1,824.50 |
| Reduction of Long Term Debt | -600.00 | -1,463.00 | -900.00 | -411.30 | -1,495.80 | -2,654.80 | -1,750.00 | -1,465.30 | -2,978.90 |
| Net Financing Active Other Cash Flow | -94.70 | -42.80 | -25.90 | -20.30 | 468.00 | -160.20 | -77.90 | -25.30 | -60.50 |
| Other Financing Activities Uses | -94.70 | -42.80 | -25.90 | -20.30 | -72.60 | -160.20 | -77.90 | -25.30 | -60.50 |
| Cash from Financing Activities | -1,564.50 | 326.00 | -484.50 | -763.50 | -843.80 | -1,306.00 | -421.80 | -779.90 | -1,302.20 |
| Exchange Rate Effect | 2.30 | 19.00 | -17.10 | 0.90 | -14.50 | -13.20 | 15.30 | -1.50 | -10.20 |
| Net Change in Cash | -892.70 | 66.40 | 109.70 | 40.10 | -102.80 | -323.60 | 184.20 | 75.10 | 18.40 |
| Free Cash Flow | 1,294.80 | 1,172.10 | 1,055.30 | 978.80 | 838.50 | 1,082.00 | 795.30 | 1,062.80 | 1,308.40 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 15.34 | 18.20 | 25.06 | 32.81 | 42.07 | 30.31 | 53.45 | 35.72 | 18.96 |
| Deferred Taxes & Investment Tax Credit | - | -87.20 | -47.70 | -96.30 | -64.40 | -102.10 | 12.00 | -538.70 | 13.40 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 399.90 | 410.00 | 424.20 | 591.90 | 1,292.70 | 556.90 |
| Short Term Receivables | 1,816.00 | 1,769.50 | 1,728.60 | 1,704.40 | 1,598.30 | 1,611.30 |
| Inventories | 2,367.20 | 2,270.30 | 2,246.80 | 2,286.40 | 2,483.70 | 2,454.20 |
| Other Current Assets | 545.90 | 646.90 | 562.90 | 537.20 | 460.30 | 431.40 |
| Total Current Assets | 5,129.00 | 5,096.70 | 4,962.50 | 5,119.90 | 5,834.90 | 5,053.90 |
| Net Property, Plant & Equipment | 2,310.40 | 2,236.80 | 2,211.70 | 2,411.30 | 2,194.30 | 2,175.70 |
| Total Investments and Advances | 12.60 | 22.20 | 22.30 | 39.40 | 75.30 | 32.20 |
| Intangible Assets | 14,970.50 | 14,381.10 | 14,479.40 | 14,664.40 | 14,441.70 | 14,600.30 |
| Other Assets | 1,116.10 | 1,061.10 | 1,045.60 | 856.70 | 941.90 | 1,003.00 |
| Total Assets | 23,538.60 | 22,797.80 | 22,721.60 | 23,091.70 | 23,488.00 | 22,865.10 |
| Short Term Debt Incl. Current Port. of LT Debt | 1,287.70 | 1,201.50 | 1,175.90 | 644.60 | 600.00 | 820.00 |
| Accounts Payable | 357.50 | 316.40 | 336.70 | 291.30 | 297.70 | 319.60 |
| Other Current Liabilities | 1,857.20 | 1,495.60 | 1,351.70 | 1,647.80 | 1,505.20 | 1,559.90 |
| Total Current Liabilities | 3,502.40 | 3,013.50 | 2,864.30 | 2,583.70 | 2,402.90 | 2,699.50 |
| Long Term Debt | 6,216.50 | 6,277.50 | 6,295.10 | 7,107.50 | 7,512.60 | 6,752.50 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 265.00 | 235.60 | 249.90 | 244.10 | - | - |
| Other Liabilities | 829.10 | 638.70 | 630.70 | 450.60 | 806.40 | 878.80 |
| Total Liabilities | 10,813.00 | 10,165.30 | 10,040.00 | 10,385.90 | 10,721.90 | 10,330.80 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 12,715.60 | 12,623.90 | 12,673.30 | 12,697.70 | 12,756.50 | 12,525.00 |
| Total Shareholders Equity | 12,715.60 | 12,623.90 | 12,673.30 | 12,697.70 | 12,756.50 | 12,525.00 |
| Accumulated Minority Interest | 10.00 | 8.70 | 8.20 | 8.10 | 9.50 | 9.30 |
| Total Equity | 12,725.60 | 12,632.60 | 12,681.50 | 12,705.80 | 12,766.00 | 12,534.30 |
| Total Liabilities & Stockholders Equity | 23,538.60 | 22,797.90 | 22,721.50 | 23,091.70 | 23,487.90 | 22,865.10 |
| Book Value Per Share | 66.89 | 66.23 | 65.53 | 64.95 | 64.36 | 63.29 |
| Tangible Book Value Per Share | -11.86 | -9.22 | -9.34 | -10.06 | -8.50 | -10.49 |
| Full-Time Employees | - | - | - | 17,000 | - | - |
| Price to Book Ratio | 1.61 | 1.31 | 1.39 | 1.40 | 1.56 | 1.46 |
| Return on Assets | 3.26 | 3.53 | 3.39 | 3.17 | 3.56 | 3.71 |
| Return on Equity | 6.03 | 6.42 | 6.07 | 5.60 | 6.41 | 6.52 |
| Return on Invested Capital | 1.01 | 1.05 | 1.26 | 0.70 | 1.14 | 0.79 |
| Quick Ratio | 0.79 | 0.94 | 0.95 | 1.10 | 1.39 | 0.96 |
| Current Ratio | 1.46 | 1.69 | 1.73 | 1.98 | 2.43 | 1.87 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 193.00 | 199.60 | 238.30 | 137.90 | 231.20 | 153.40 |
| Depreciation | 282.00 | 270.80 | 270.00 | 284.00 | 283.60 | 271.80 |
| Other Funds (Non Cash) | 24.10 | 24.50 | 24.40 | 24.00 | 25.30 | 21.20 |
| Funds from Operations | 499.10 | 494.90 | 532.70 | 358.70 | 540.10 | 446.40 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 60.90 | -47.10 | -173.30 | 158.70 | -121.40 | -68.20 |
| Income Taxes Payable | 4.90 | -72.70 | -7.40 | 8.10 | -42.70 | -116.40 |
| Cash from Operating Activities | 560.00 | 447.80 | 359.40 | 517.40 | 418.70 | 378.20 |
| Capital Expenditures | -212.60 | -201.80 | -152.50 | -159.10 | -151.00 | -160.60 |
| Net Assets From Acquisitions | -359.40 | 0.00 | 0.00 | -166.90 | 0.00 | -1,226.30 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 28.70 | 11.10 | -0.30 | 4.90 | -8.80 | 2.50 |
| Purchase of Investments | 0.00 | 0.30 | -0.30 | 4.90 | -5.30 | 0.00 |
| Sale Or Maturity of Investments | 28.70 | 10.80 | 0.00 | 0.00 | -3.50 | 2.50 |
| Other Uses | 0.00 | -0.10 | -6.20 | -0.90 | -3.50 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -543.30 | -190.80 | -159.00 | -322.00 | -163.30 | -1,384.40 |
| Cash Dividends Paid | -45.80 | -46.50 | -46.90 | -47.50 | -47.50 | -47.50 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -65.10 | -250.60 | -237.80 | -248.30 | 20.90 | -6.80 |
| Repurchase of Common Pref Stock | -78.50 | -250.70 | -250.10 | -250.00 | 0.00 | -7.20 |
| Sale of Common Pref Stock | 13.40 | 0.10 | 12.30 | 1.70 | 20.90 | 0.40 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 90.00 | 28.70 | 0.00 | -600.00 | 518.60 | 218.80 |
| Change in Long Term Debt | 90.00 | 28.70 | 0.00 | -600.00 | 518.60 | 218.80 |
| Issuance of Long Term Debt | 90.00 | 28.70 | 0.00 | 0.00 | 518.60 | 218.80 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | -600.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -6.40 | -2.50 | -84.60 | -1.20 | -8.10 | -0.90 |
| Other Financing Activities Uses | -6.40 | -2.50 | -84.60 | -1.20 | -8.10 | -0.90 |
| Cash from Financing Activities | -27.20 | -271.10 | -369.20 | -897.00 | 483.80 | 163.80 |
| Exchange Rate Effect | 0.40 | 0.00 | 1.10 | 0.80 | -3.40 | 14.60 |
| Net Change in Cash | -10.10 | -14.10 | -167.70 | -700.80 | 735.80 | -827.80 |
| Free Cash Flow | 372.40 | 308.20 | 245.90 | 368.30 | 277.70 | 247.60 |
| Price to Free Cash Flow | 15.34 | 16.41 | 18.63 | 18.14 | 19.28 | 17.28 |
Revenue breakdown
| Consolidation, Policy | 2025: -100.00K |
|---|---|
| Hips | 2024: 2.00B 2025: 2.09B |
| Knees | 2024: 3.17B 2025: 3.32B |
| Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic | 2024: 1.87B 2025: 2.15B |
| Technology And Data, Bone Cement and Surgical | 2024: 640.30M 2025: 665.60M |
| Americas | 2024: 4.79B 2025: 5.14B |
| Asia Pacific | 2024: 1.19B 2025: 1.26B |
| Consolidation, Policy | 2024: -100.00K |
| EMEA | 2024: 1.69B 2025: 1.83B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 4.15% | 7.8M | 188.9M | 2.09M |
| 2026-10-15 | 4.18% | 8.0M | 190.4M | 2.13M |
| 2026-09-30 | 5.12% | 9.7M | 190.4M | 2.18M |
| 2026-09-15 | 4.50% | 8.6M | 190.4M | 2.23M |
| 2026-08-31 | 4.62% | 8.8M | 190.3M | 2.24M |
| 2026-08-14 | 4.62% | 8.8M | 190.3M | 2.41M |
| 2026-07-31 | 5.87% | 11.2M | 190.4M | 2.28M |
| 2026-07-15 | 6.24% | 12.1M | 193.1M | 2.43M |
| 2026-06-30 | 6.12% | 11.8M | 193.1M | 2.36M |
| 2026-06-15 | 6.05% | 11.7M | 193.0M | 2.27M |
| 2026-05-29 | 4.51% | 8.7M | 193.1M | 2.30M |
| 2026-05-15 | 4.75% | 9.2M | 193.1M | 2.26M |
| 2026-04-30 | 5.18% | 10.0M | 193.1M | 2.34M |
| 2026-04-15 | 5.22% | 10.1M | 193.3M | 2.16M |
| 2026-03-31 | 5.12% | 10.0M | 195.4M | 2.23M |
| 2026-03-13 | 4.10% | 8.0M | 195.4M | 2.19M |
| 2026-02-27 | 3.94% | 7.7M | 195.4M | 2.19M |
| 2026-02-13 | 4.31% | 8.4M | 195.4M | 2.21M |
| 2026-01-30 | 4.95% | 9.8M | 197.9M | 2.29M |
| 2026-01-15 | 4.78% | 9.5M | 197.9M | 2.14M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 55.00 | 50.40 | 52.80 | 0.00 | 2.288 | 0.00 | 0.00 | 0.983 | -0.090 | 0.007 |
| call | 60.00 | 45.40 | 47.80 | 0.00 | 2.017 | 0.00 | 0.00 | 0.981 | -0.089 | 0.008 |
| call | 65.00 | 40.40 | 42.80 | 0.00 | 1.768 | 0.00 | 0.00 | 0.978 | -0.087 | 0.009 |
| call | 70.00 | 35.40 | 37.90 | 0.00 | 1.622 | 0.00 | 0.00 | 0.975 | -0.086 | 0.010 |
| call | 75.00 | 30.40 | 32.90 | 0.00 | 1.396 | 0.00 | 0.00 | 0.971 | -0.084 | 0.011 |
| call | 80.00 | 25.40 | 27.90 | 0.00 | 1.182 | 0.00 | 0.00 | 0.967 | -0.081 | 0.012 |
| call | 85.00 | 20.50 | 23.00 | 26.50 | 1.030 | 6.00 | 0.00 | 0.960 | -0.078 | 0.014 |
| call | 90.00 | 15.50 | 18.00 | 6.94 | 0.826 | 46.00 | 0.00 | 0.951 | -0.074 | 0.017 |
| call | 95.00 | 10.60 | 13.50 | 13.20 | 0.778 | 51.00 | 0.00 | 0.879 | -0.143 | 0.034 |
| call | 100 | 6.50 | 8.30 | 9.35 | 0.502 | 1,193 | 0.00 | 0.827 | -0.132 | 0.043 |
| call | 105 | 2.75 | 4.30 | 3.10 | 0.433 | 519 | 7.00 | 0.621 | -0.215 | 0.064 |
| call | 110 | 0.50 | 1.25 | 1.01 | 0.337 | 59.00 | 0.00 | 0.379 | -0.157 | 0.064 |
| call | 115 | 0.00 | 0.35 | 0.35 | 0.360 | 52.00 | 1.00 | 0.154 | -0.094 | 0.040 |
| call | 120 | 0.00 | 0.75 | 0.42 | 0.512 | 6.00 | 0.00 | 0.091 | -0.080 | 0.027 |
| call | 125 | 0.00 | 0.70 | 0.13 | 0.649 | 1.00 | 0.00 | 0.075 | -0.088 | 0.024 |
| call | 130 | 0.00 | 0.70 | 0.00 | 0.774 | 0.00 | 0.00 | 0.065 | -0.093 | 0.021 |
| call | 135 | 0.00 | 1.00 | 0.14 | 0.890 | 2.00 | 0.00 | 0.058 | -0.098 | 0.019 |
| call | 140 | 0.00 | 0.75 | 0.00 | 0.999 | 0.00 | 0.00 | 0.053 | -0.102 | 0.018 |
| call | 145 | 0.00 | 0.80 | 0.00 | 1.102 | 0.00 | 0.00 | 0.049 | -0.106 | 0.017 |
| put | 55.00 | 0.00 | 2.15 | 0.00 | 2.205 | 0.00 | 0.00 | -0.017 | -0.087 | 0.007 |
| put | 60.00 | 0.00 | 0.80 | 0.00 | 1.949 | 0.00 | 0.00 | -0.019 | -0.085 | 0.008 |
| put | 65.00 | 0.00 | 0.95 | 0.00 | 1.712 | 0.00 | 0.00 | -0.021 | -0.083 | 0.009 |
| put | 70.00 | 0.00 | 0.60 | 0.00 | 1.490 | 0.00 | 0.00 | -0.025 | -0.081 | 0.010 |
| put | 75.00 | 0.00 | 0.60 | 0.05 | 1.282 | 20.00 | 0.00 | -0.028 | -0.078 | 0.011 |
| put | 80.00 | 0.00 | 0.60 | 0.08 | 1.084 | 63.00 | 0.00 | -0.033 | -0.075 | 0.012 |
| put | 85.00 | 0.00 | 0.80 | 0.10 | 0.896 | 236 | 0.00 | -0.039 | -0.072 | 0.014 |
| put | 90.00 | 0.05 | 0.25 | 0.15 | 0.713 | 2,821 | 1.00 | -0.048 | -0.067 | 0.017 |
| put | 95.00 | 0.00 | 0.75 | 0.30 | 0.716 | 30.00 | 0.00 | -0.121 | -0.135 | 0.034 |
| put | 100 | 0.00 | 0.85 | 0.30 | 0.522 | 16.00 | 1.00 | -0.173 | -0.124 | 0.043 |
| put | 105 | 0.65 | 3.30 | 1.30 | 0.676 | 1,020 | 1.00 | -0.379 | -0.206 | 0.064 |
| put | 110 | 2.80 | 5.20 | 4.10 | 0.571 | 14.00 | 0.00 | -0.621 | -0.148 | 0.064 |
| put | 115 | 7.30 | 9.40 | 0.00 | 0.693 | 0.00 | 0.00 | -0.845 | -0.084 | 0.040 |
| put | 120 | 12.10 | 14.60 | 0.00 | 0.992 | 0.00 | 0.00 | -0.909 | -0.070 | 0.027 |
| put | 125 | 17.00 | 19.60 | 0.00 | 1.179 | 0.00 | 0.00 | -0.925 | -0.076 | 0.024 |
| put | 130 | 22.20 | 24.60 | 0.00 | 1.349 | 0.00 | 0.00 | -0.935 | -0.082 | 0.021 |
| put | 135 | 27.10 | 29.60 | 0.00 | 1.505 | 0.00 | 0.00 | -0.942 | -0.086 | 0.019 |
| put | 140 | 32.20 | 34.60 | 0.00 | 1.650 | 0.00 | 0.00 | -0.947 | -0.089 | 0.018 |
| put | 145 | 37.00 | 39.60 | 0.00 | 1.785 | 0.00 | 0.00 | -0.951 | -0.092 | 0.017 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-09 | 424B5 | SEC | ||
| 2026-11-09 | 424B5 | SEC | ||
| 2026-11-05 | FWP | Filing under Securities Act Rule 163/433 of free writing prospectuses. | SEC | |
| 2026-11-05 | FWP | Filing under Securities Act Rule 163/433 of free writing prospectuses. | SEC | |
| 2026-11-05 | 424B5 | SEC | ||
| 2026-11-05 | 424B5 | SEC | ||
| 2026-11-04 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-04 | 8-K | Current report | 2026-11-04 | SEC |
| 2026-10-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-10-05 | 3 | Initial statement of beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-10-05 | 3 | Initial statement of beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-10-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-30 | SEC |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-11 | SEC |
| 2026-09-11 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-04 | SEC |
| 2026-09-08 | 8-K | Current report | 2026-09-08 | SEC |
| 2026-09-04 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-13 | SCHEDULE 13G/A | SEC | ||
| 2026-08-12 | SCHEDULE 13G | SEC | ||
| 2026-08-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-03 | SEC |
| 2026-08-05 | 8-K | Current report | 2026-08-05 | SEC |
| 2026-08-05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-05 | 8-K | Current report | 2026-08-05 | SEC |
| 2026-08-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-01 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 824.03K | 2 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 413.22K | 1 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 250.85K | 1 |
| 2026-02 | 0 | 0 | 96.49K | 1 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| DODGE & COX | 12.47% |
| BlackRock, Inc. | 8.07% |
| HARRIS ASSOCIATES L P | 6.58% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.53% |
| Capital International Investors | 6.30% |
| STATE STREET CORP | 4.59% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.82% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.48% |
| Invesco Ltd. | 2.06% |
Funds
| Fund | % owned |
|---|---|
| JPMorgan Ultra-Short Income ETF | 42.53% |
| VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND | 23.09% |
| VANGUARD INSTITUTIONAL INTERMEDIATE-TERM BOND FUND | 21.72% |
| PGIM Total Return Bond Fund | 18.09% |
| VANGUARD SHORT-TERM INVESTMENT-GRADE FUND | 16.51% |
| First Trust Enhanced Short Maturity ETF | 15.51% |
| VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND | 14.68% |
| VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND | 12.98% |
| VANGUARD ULTRA-SHORT BOND ETF | 11.18% |
| JPMorgan Managed Income Fund | 8.62% |
OakChart. ZBH. Cached 15 minutes.